在透析患者中,人群内侧绕道:患者的患者性和生存率
Armanda Duarte1, Tony R Soares1, Gonçalo Cabral1
1Department of Angiology and Vascular Surgery, Hospital Beatriz Ângelo, Loures, Portugal.
概括
与非透析患者相比,在透析中接受因慢性四肢威胁性缺血症 (CLTI) 之类的内皮皮层绕道治疗的患者的四肢挽救和存活率相似. 然而,透析患者的初级通透率较低.
科学领域:
- 血管外科 血管外科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
背景情况:
- 葡萄牙有大量需要定期透析的患者.
- 透析患者患外周动脉疾病的发病率增加,导致术后并发症的风险更高.
- 慢性四肢威胁性缺血症 (CLTI) 在这种患者群体中带来了重大挑战.
研究的目的:
- 为了比较常规透析和非透析的患者之间CLTI的infrapopliteal绕道手术的结果.
- 评估关键临床终点的差异,包括肢体救援,存活率和移植透度.
主要方法:
- 一项回顾性单一中心研究包括了310名患有CLTI的患者,他们在2012年至2019年期间接受了底外围手术.
- 患者被分为两组:透析患者和非透析患者.
- 评估的结果包括1年免受CLTI,3年肢体挽救,存活率,初级通透性 (PP) 和三级通透性 (TP).
主要成果:
- 总共分析了352个绕道手术,其中14%是在透析患者身上进行的.
- 两组之间在30天死亡率,免受CLTI,肢体挽救或存活率方面没有发现显著差异.
- 透析患者的初级通透率 (PP) 显著降低 (39%对64%;p=0.030).
结论:
- 在透析患者中,对CLTI的Infrapopliteal绕道手术产生了与非透析患者相比的免于CLTI,四肢挽救和生存率.
- 一个值得注意的发现是,在这些程序后,透析患者的初级通透率 (PP) 降低.
- 三级通透性 (TP) 在两组之间没有显示出统计学上显著的差异.
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...